TMCnet News
IMS Health and Remedy Informatics to Collaborate on Real-World Evidence SolutionsMay 22, 2013 (Close-Up Media via COMTEX) -- IMS Health and Remedy Informatics announced a strategic alliance to deliver technology-enabled Real-World Evidence (RWE) solutions for life sciences organizations worldwide. According to a release, the alliance brings together IMS Health's RWE capabilities and anonymous patient-level information assets with Remedy Informatics' Mosaic technology solution - providing the industry's most complete understanding of healthcare effectiveness, safety and value. The combination extends IMS Health's scalable RWE platform, which leverages proprietary technology to connect and analyze de-identified patient information from sources that include disease registries, electronic health records and claims databases. The new suite of solutions will be offered as IMS Evidence 360. Applying flexible data integration, visualization and reporting applications, IMS Evidence 360 will enable pharmaceutical and medical device manufacturers, payers and providers to link and analyze complex healthcare data sets. It will be a key component of IMS Health's expanded RWE platform supporting a broad range of applications, from epidemiological studies and comparative effectiveness and safety research, to commercial analytics. "Today, life sciences organizations recognize the increasing role of real-world evidence in facilitating a deeper understanding across the patient journey - and the power of technology in advancing the healthcare value dialogue," said Andrew Kress, senior vice president, IMS Healthcare Value Solutions. "With this alliance, we are bringing together proven expertise, scalable applications and the industry's most robust data management and structured analytics to enable innovative, integrated patient-level insights." Organizers said that IMS Evidence 360 will feature a number of enhanced capabilities, including: -Seamless data integration to create novel disease-centric information assets across clinical, observational and claims data sets -Advanced data capture and registry building -Sophisticated, therapy area-specific analyses applying customized disease definitions -Flexible user interface for dynamic, efficient research functionality, including queries to identify patterns without complex programming -Intuitive visual interrogation, reporting and dashboarding tools to facilitate analytical workflow and cohort building "We are pleased to enter this agreement with IMS Health," said Gary Kennedy, founder and CEO, Remedy Informatics. "A key challenge for life sciences clients is how to best connect and integrate data for a complete picture of the patient experience. Only IMS Health has the breadth of anonymous patient-level data assets - and depth of HEOR expertise. Remedy Informatics' technology can combine that kind of insight with the harmonization and rigor only our Mosaic Platform can offer. Together, we will deliver next-generation solutions that support healthcare stakeholders in examining the real-world costs, risks and benefits of specific treatments." Remedy Informatics is a provider of patient registries, medical research software and research informatics products that accelerate translational medicine discoveries from bench to bedside. IMS Health is a provider of information, technology and services dedicated to making healthcare perform better. More information: www.remedyinformatics.com www.imshealth.com ((Comments on this story may be sent to [email protected])) |
